Navigation Links
SENOMYX AND FIRMENICH TO COLLABORATE ON DISCOVERY, DEVELOPMENT AND WORLDWIDE COMMERCIALIZATION OF NOVEL SWEET ENHANCERS
Date:8/3/2009

ury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit www.senomyx.com.

Firmenich Company Profile

Firmenich is the largest privately-owned company (No.2 worldwide) in the perfume and flavor business. Swiss, family-owned and founded in Geneva in 1895, it has created many of the world's best-known perfumes and flavors that you enjoy each day. Its passion for smell and taste is at the heart of its success. It is renowned for its creativity and innovation, as well as its exceptional understanding of consumer trends. Every year, it invests around 10% of its turnover in R&D, reflecting its continued desire to understand, share and sublimate the best that nature has to offer. The annual turnover for Firmenich was 2.847 million Swiss francs at end-June 2008.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: Senomyx's rights to the remaining license fee and our ability to achieve the specified events for receiving such payment; Senomyx's ability to discover and develop novel flavor ingredients for use as sweet enhancers of sucrose, fructose and Rebaudioside (stevia); the capabilities and potential uses of Senomyx's flavor ingredients; Senomyx's ability or Firmenich's ability to commercialize products incorporating Senomyx's flavor ingredients for use in
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. SENOMYX, INC. SECOND QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR AUGUST 4, 2009
2. SENOMYX ANNOUNCES APPOINTMENT OF DAVID L. LINEMEYER, PH.D., AS VICE PRESIDENT, BIOLOGY
3. SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS
4. SENOMYX ANNOUNCES NESTLES SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL
5. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
6. SENOMYX ANNOUNCES EXTENSION OF ITS COLLABORATION WITH CAMPBELL SOUP COMPANY
7. SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.
8. SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS
9. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS
10. SENOMYX, INC. fourth quarter AND FISCAL YEAR-END 2008 Earnings conference call scheduled for February 12, 2009
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...merican countries have an opportunity to take the ...rs from the University of Valencia (UV), working t...the productive fabric of the Spanish biotechnology...nd plant sectors have more clout than those in Eng...ied to food and plants has been overlooked by the ...
(Date:11/20/2009)...TLE, Nov. 20 Cell Therap...d today that the Ninth Circuit Court of Appeals re...CTI should be allowed to pursue all of its claims ...he District Court for trial. CTI filed a complain... reimbursement consultant for CTI,s product TRISEN...
(Date:11/19/2009)... Nov. 19 Omeros Corporat...ancial results for the third quarter ended Septemb...30, 2009, Omeros reported a net loss of $3.9 milli...of $7.4 million, or $2.54 per share, for the same ...r 30, 2009, the Company reported a net loss of $15...
(Date:11/19/2009)...ERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewswire/ ...Resources find that the leading driver of antibiot...broad-spectrum activity against gram-positive and ...anisms that can cause nosocomial pneumonia, survey...rily for agents that provide appropriate coverage ...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...alifax-based consumer health products company reco...Nova Scotia, Jan. 27 Origin BioMed Inc., a privat..., today announced that it has been awarded as one ... , Red Herring Top 100 Global Companies are chosen...itions for North America, Europe and Asia Red Herr...
...EW YORK, Jan. 27 Technology and consulting firm, ...acle Partner Network, today announced year over ye...continue the positive trend in 2009. The company,...f flat to low single digit growth for the U.S. IT...rn affects IT services spending across most indust...
... ST. LOUIS and DURHAM, N.C., Jan. 27 As farmers.... Louis-based Monsanto,(NYSE: MON ) is exploring...e,traits through the seed. Monsanto,s new collabor...ed to do just that by expanding the benefits of,Mo...rmer customer. , Today, Monsanto announced tha...
Other Biology Technology:Origin BioMed Awarded Red Herring Top 100 Global Company 2Origin BioMed Awarded Red Herring Top 100 Global Company 3Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 2New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 3New Collaboration Aims To Expand Seed-Based Technologies, Benefit Farmers 4
(Date:11/20/2009)...North Grafton, Mass., November 19, 2009 The estim...industry may be at risk of developing respiratory ...ccording to a questionnaire study undertaken earli...s Cummings School of Veterinary Medicine. , The ...arn workersfound that 50 percent of individuals wo...
(Date:11/20/2009)... This release is available in German . , In...cal Investigation , Dr. Stefanie Eyerich and Dr. K...Imperial College London and Istituto Dermopatico d...ng discovery. It represents a milestone on the way...ory skin diseases such as psoriasis and allergic r...
(Date:11/20/2009)...CHAMPAIGN, Ill. In a new study, researchers repor...ockers can have a helpful, or harmful, effect on t..., The study, which appears in the journal Circul...get both the alpha- and beta-receptors on the hear...s, while those that target only the beta-receptors...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2University of Toronto helps to barcode the worlds plants 9394 1University of Toronto helps to barcode the worlds plants 9394 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
...mproved aerodynamic shape for truck trailers by mo...ption and emissions of up to as much as 15%. Earli...dels and wind tunnel tests by TU Delft, have been ...r. This means that public-private platform PART (P...ced an application which can immediately be put in...
...e most common cause of episodic headache, and by f... visit. It affects some 15% of the population, inc...s a considerable burden on healthcare in both the ... last few years, great strides have been made in d...lity to common diseases, such as diabetes, Crohns ...
...y: New evidence has emerged that, contrary to some... associated with an increased risk of heart proble...cancer recurring. , In a study presented today (T...nce (EBCC-6) in Berlin, the researcher, Dr Alain M...g news for women. , AIs, such as letrozole, anast...
Other Biology News:Aerodynamic trailer cuts fuel and emissions by up to 15 percent 2Concentrating on different aspects of pain leads to breakthrough in migraine genetics 2New research shows no link between aromatase inhibitors and cardiovascular problems 2New research shows no link between aromatase inhibitors and cardiovascular problems 3
Goat Anti-SDF-1 beta / PBSF Polyclonal Antibody, Unconjugated from Sigma-Aldrich
Immulon 4 HBX 1x12 Strip from Thermo Scientific
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Enterokinase from bovine intestine from Sigma-Aldrich
Biology Products: